ELI LILLY & Co SEC filings LLY

ELI LILLY & Co has 1,001 filings in SEC EDGAR's recent list, going back to Feb 3, 2022. Its latest annual report, Form 10-K, was filed on Feb 12, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.

ELI LILLY & Co SEC filings
Form Description Filed Period
8-K Current report
Results of operations
Oct 29, 2026 Oct 29, 2026
8-K Current report
Results of operations
Aug 5, 2026 Aug 5, 2026
8-K Current report
Other events
May 20, 2026 May 20, 2026
8-K Current report
Shareholder vote results
May 7, 2026 May 4, 2026
8-K Current report
Results of operations
Apr 30, 2026 Apr 30, 2026
8-K Current report
Results of operations
Feb 4, 2026 Feb 4, 2026
8-K Current report
Officer or director change
Nov 21, 2025 Nov 18, 2025
8-K Current report
Results of operations
Oct 30, 2025 Oct 30, 2025
8-K Current report
Other events
Aug 20, 2025 Aug 18, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
8-K Current report
Shareholder vote results
May 8, 2025 May 5, 2025
8-K Current report
Results of operations
May 1, 2025 May 1, 2025
8-K Current report
Other events
Feb 12, 2025 Feb 10, 2025
8-K Current report
Results of operations
Feb 6, 2025 Feb 6, 2025
8-K Current report
Results of operations
Jan 14, 2025 Jan 14, 2025
8-K Current report
Officer or director change
Nov 19, 2024 Nov 19, 2024
8-K Current report
Results of operations
Oct 30, 2024 Oct 30, 2024
8-K Current report
Officer or director change
Sep 9, 2024 Sep 5, 2024
8-K Current report
Officer or director change
Aug 16, 2024 Aug 13, 2024
8-K Current report
Other events
Aug 14, 2024 Aug 12, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
8-K Current report
Officer or director change
Jul 10, 2024 Jul 5, 2024
8-K Current report
Officer or director change
Jun 5, 2024 Jun 2, 2024
8-K Current report
Shareholder vote results
May 9, 2024 May 6, 2024
8-K Current report
Results of operations
Apr 30, 2024 Apr 30, 2024
8-K Current report
Other events
Feb 9, 2024 Feb 7, 2024
8-K Current report
Results of operations
Feb 6, 2024 Feb 6, 2024
8-K Current report
Results of operations
Nov 2, 2023 Nov 2, 2023
8-K Current report
Results of operations
Aug 8, 2023 Aug 8, 2023
8-K Current report
Shareholder vote results
May 4, 2023 May 1, 2023
8-K Current report
Results of operations
Apr 27, 2023 Apr 27, 2023
8-K Current report
Officer or director change
Mar 17, 2023 Mar 17, 2023
8-K Current report
Other events
Feb 24, 2023 Feb 23, 2023
8-K Current report
Results of operations
Feb 2, 2023 Feb 2, 2023
8-K Current report
Results of operations
Dec 13, 2022 Dec 13, 2022
8-K Current report
Results of operations
Nov 1, 2022 Nov 1, 2022
8-K Current report
Other events
Oct 12, 2022 Oct 12, 2022
8-K Current report
Results of operations
Aug 4, 2022 Aug 4, 2022
8-K Current report
Officer or director change
May 6, 2022 May 2, 2022
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
May 4, 2022 May 2, 2022
8-K Current report
Results of operations
Apr 28, 2022 Apr 28, 2022
8-K Current report
Results of operations
Apr 14, 2022 Apr 14, 2022
8-K Current report
Results of operations
Feb 3, 2022 Feb 3, 2022

Showing 43 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
LLY (NYSE)
Fiscal year ends
December 31
Incorporated in
IN
Headquarters
Indianapolis, IN
SEC filer status
Large accelerated filer
SEC CIK
59478
Former names
LILLY ELI & CO (until Oct 25, 2019); LILLY ELI & CO ET AL (until Oct 14, 1994)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.